Glomerular Precision Nephrology: Novel Mechanisms, Biomarkers, and Therapeutic Targets
Back to course
Video Transcription
Video Summary
Asset Subtitle

Moderator(s): Eunsil Hahm, Kristin Meliambro

Presentation(s):
  • Single-Cell Multiomics Analysis of Human Kidney Diseases - Turgay Saritas
  • Downregulation of PARD6B Is Associated with Irreversible Podocyte Damage in FSGS - Katsuaki Shibata
  • Nephrin Trafficking in the Mouse Model of Experimental Autoimmune Nephrotic Syndrome - Soichiro Suzuki
  • Targeting of CLDN1 Reduces Kidney Injury and Macrophage Infiltration in FSGS - Geoffrey Teixeira
  • A Novel Tool to Study Glomerular Endothelial Cell Biology - Chelsea Estrada
  • Kidney-Specific Four-Protein Index Outperforms Conventional Measures for Detecting Early Kidney Damage in Lupus Nephritis and Diabetic Kidney Disease - Mike Nerenberg
  • Change in Soluble Biomarker Levels in Patients with IgAN: Analysis of the Phase 2 Trial of Ravulizumab (SANCTUARY) - Tobin Cammett
  • Integration of Pathomic Signatures and Spatial Transcriptomics Reveals Tubular Morphometric Trajectories and Enables Patient Stratification in Minimal Change Disease (MCD)/FSGS - Fan Fan
  • Senescence as an Underlying Mechanism of Podocyte Injury in Preeclampsia - Sonja Suvakov

Note: Continuing education credits are not being offered for this session.
Meta Tag
Date 11/6/2025
Pathway 1 Glomerular Diseases
Session ID 519868
Keywords
Glomerular precision nephrology
single-cell RNA-seq
spatial transcriptomics
kidney fibrosis IFTA
NF-kappaB RELA signaling
adaptive proximal tubule cells
podocyte polarity PARD6B
FSGS nephrin mislocalization
CRB2 autoantibodies
claudin-1 CD44 parietal epithelial cells
EHD3-rtTA glomerular endothelium
plasma 4-protein kidney damage index
ravulizumab C5 inhibition IgA nephropathy